Artificial intelligence in unveiling herbal remedies for cancer: Advances and applications

Authors

DOI:

https://doi.org/10.3329/bsmmuj.v18i1.76190 

Keywords

artificial intelligence, natural remedies, cancer treatment

Correspondence

Harshal Tare 
Email: harshaltare51@gmail.com

Publication history

Received: 17 Sep 2024
Accepted: 5 Jan 2025
Published inline: 4 Feb 2025

Handling editor

Reviewers

A: Anonymous
B: Anonymous 

Funding

None declared

Ethical approval

Not applicable

Trial registration number

Not applicable

Copyright

© The Author(s) 2025; all rights reserved
Published by Bangabandhu Sheikh
Mujib Medical University

Key messages
Artificial intelligence have revolutionised herbal anticancer medication discovery. AI has predicted bioactive molecules and optimised drug synergy. Improved clinical trial designs and customised therapy have boosted cancer herbal medicine research. Data quality, model transparency challenges and AI-driven strategies to expedite herbal cancer treatment development conclude the article. AI models could find new natural anticancer compounds, revolutionising cancer treatment.
Cancer continues to pose a significant global health burden, with millions of new cases diagnosed each year. Despite advances in conventional treatments such as chemotherapy, radiation, and immunotherapy, these approaches often come with considerable challenges, including severe side effects, treatment resistance, and high costs. Artificial intelligence (AI) technologies such as Machine Learning and Deep Learning offer significant promise to overcome such challenges.[1] Machine learning techniques aid in discovering novel medications by analysing large datasets to predict the activity and efficacy of new compounds. It accelerates drug discovery by automating screening and modelling drug-target interactions, reducing time and costs compared to traditional methods. Deep learning, using artificial neural networks, analyses large datasets to identify complex patterns. In pharmaceuticals, deep learning predicts drug functionality, identifies treatment targets, and decodes biological structures, accelerating drug discovery and improving treatment outcomes. AI can be highly useful not only in the novel drug discovery but also in identification of promising anticancer compounds of natural origin. Herbal remedies are complex, containing multiple active constituents that often work synergistically. One requirement is the need for more stringent clinical validation.[2]
For the literature search in this commentary, specific inclusion and exclusion criteria were applied to ensure relevant studies were selected. Inclusion criteria included: (1) studies focused on the use of AI techniques (such as machine learning, deep learning, and natural language processing) in discovering herbal remedies for cancer. Exclusion criteria included: (1) studies not related to AI. AI plays a crucial role in personalized herbal treatments by integrating patient data (genetic, medical, lifestyle) to customize therapies, using predictive analytics to forecast responses and adjust treatments based on feedback for optimal outcomes and minimized side effects.[3
AI implementation in herbal medicine faces several technical challenges. Data quality and accessibility issues include gaps in critical information, which limit prediction accuracy, and difficulties in integrating diverse data sources due to varying formats and standards. Algorithm limitations arise from models trained on specific datasets that may not generalize well to new or unseen data, particularly for diverse herbal compounds and patient populations. The complexity of herbal mixtures, with multiple active constituents, adds another challenge, as AI models may struggle to capture their synergistic effects. Additionally, high computational demands for advanced AI models can be a barrier for smaller research labs or organizations lacking access to powerful computing resources.[4]
AI techniques have significantly enhanced herbal drug discovery for cancer, with machine learning models identifying promising compounds like curcumin, paclitaxel, camptothecin, resveratrol and Epigallocatechin-3-gallate. Deep learning and natural language processing have accelerated drug-target interaction predictions, extracting key insights from databases with published studies. Advancements like transfer learning and Graph Neural Networks have optimized herbal compound synergy, increasing the accuracy of compound-target interaction models by 15%. Platforms like Atomwise have improved the success rate for compounds with anticancer potential by 30%, while DeepChem has significantly improved the discovery methodology (Table 1).[5]
Table 1 Summary of the applications of AI in drug discovery 

Application

Description

AI techniques used

Benefits

Relevance to drug discovery

Identification of target 

AI analyzes extensive datasets to detect proteins, genes, or pathways affecting disease mechanisms, aiding in identifying promising targets. 

Machine learning, data mining 

Focuses research on the most promising targets 

Target identification is crucial for the success of drug discovery, helping streamline the search for effective treatments.

Substance testing 

AI optimizes drug screening by predicting the most effective compounds, reducing the need for extensive experimental testing. 

Predictive models, convolutional neural networks 

Reduces experimental workload, accelerates discovery process 

AI’s predictive capabilities enhance efficiency by narrowing down the best candidates, saving time and resources. 

Predictive modelling 

AI-driven models predict ADMETa properties of drug candidates, helping assess potential effectiveness and safety before experimental validation. 

Statistical techniques, machine learning 

Expedites and reduces costs of drug development 

Predictive modelling reduces failure rates in clinical trials by assessing the safety and efficacy of drugs early in the process. 

Drug repurposing 

AI finds new therapeutic uses for approved drugs by uncovering correlations between drugs and diseases. 

Data analysis, natural language processing 

Accelerates development using existing safety and efficacy data 

Drug repurposing is a cost-effective strategy to quickly find new treatments, leveraging existing drugs for new indications. 

aADMET indicates absorption, distribution, metabolism, elimination and toxicity

Recognizing there are benefits to using AI to identify herbal anticancer agents, but there are challenges to overcome before implementation. The biggest challenge is data quality and accessibility. AI models need datasets to provide accurate predictions and insights. However, herbal medicine databases lack consistency, accessibility, and comprehensiveness. AI model creation is difficult due to the lack of formal documentation for many traditional knowledge systems and uneven dataset quality. AI struggles to acquire worldwide researchers' and clinicians' trust in innovative drug discovery, where clinical validation and regulatory approval are crucial.[6]
It can be concluded that AI has the capacity to enhance accuracy, expedite the discovery and optimise clinical studies in order to revolutionise the antineoplastic treatments with special reference to bioactive molecules.

Categories

Number (%)

Sex

 

   Male

36 (60.0)

   Female

24 (40.0)

Age in yearsa

8.8 (4.2)

   Education

 

   Pre-school

20 (33.3)

   Elementary school

24 (40.0)

   Junior high school

16 (26.7)

Cancer diagnoses

 

   Acute lymphoblastic leukemia

33 (55)

   Retinoblastoma

5 (8.3)

   Acute myeloid leukemia

4 (6.7)

   Non-Hodgkins lymphoma

4 (6.7)

   Osteosarcoma

3 (5)

   Hepatoblastoma

2 (3.3)

   Lymphoma

2 (3.3)

   Neuroblastoma

2 (3.3)

   Medulloblastoma

1 (1.7)

   Neurofibroma

1 (1.7)

   Ovarian tumour

1 (1.7)

   Pancreatic cancer

1 (1.7)

   Rhabdomyosarcoma

1 (1.7)

aMean (standard deviation)

Categories

Number (%)

Sex

 

   Male

36 (60.0)

   Female

24 (40.0)

Age in yearsa

8.8 (4.2)

Education

 

   Pre-school

20 (33.3)

   Elementary school

24 (40.0)

   Junior high school

16 (26.7)

Cancer diagnoses

 

Acute lymphoblastic leukemia

33 (55)

Retinoblastoma

5 (8.3)

Acute myeloid leukemia

4 (6.7)

Non-Hodgkins lymphoma

4 (6.7)

Osteosarcoma

3 (5)

Hepatoblastoma

2 (3.3)

Lymphoma

2 (3.3)

Neuroblastoma

2 (3.3)

Medulloblastoma

1 (1.7)

Neurofibroma

1 (1.7)

Ovarian tumour

1 (1.7)

Pancreatic cancer

1 (1.7)

Rhabdomyosarcoma

1 (1.7)

aMean (standard deviation)

Acknowledgements
None
Author contributions
Conception or design of the work; or the acquisition, analysis, or interpretation of data for the work: BSS, SHK, AHK, NG, AK. Drafting the work or reviewing it critically for important intellectual content: NG, AK. Final approval of the version to be published: BSS, HT. Accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved: HT.
Conflict of interest
We do not have any conflict of interest.
Data availability statement
Not applicable
Supplementary file
None
    References
    1. Dixit U, HK S, Bargale SS, Gaikwad A, Deshpande M, Tare H. Ayurvedic treatment of a case diagnosed as AIDS and diffuse large B cell lymphoma-Case report. Multidisciplinary Science Journal. 2023 Jun 8;5(4): 2023049. DOI: https://doi.org/10.31893/multiscience.2023049
    [Google Scholar]
    2. Weiss F, Lauffenburger D, Friedl P. Towards targeting of shared mechanisms of cancer metastasis and therapy resistance. Nat Rev Cancer. 2022 Mar;22(3):157-173. DOI: https://doi.org/10.1177/0.1038/s41568-021-00427-0
    [PubMed]     [Google Scholar]
    3. Sharma M, Bakshi AK, Mittapelly N, Gautam S, Marwaha D, Rai N, Singh N, Tiwari P, Agarwal N, Kumar A, Mishra PR. Recent updates on innovative approaches to overcome drug resistance for better outcomes in cancer. J Control Release. 2022 Jun;346:43-70. DOI: https://doi.org/10.1016/j.jconrel.2022.04.007
    [PubMed]     [Google Scholar]
    4. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209-249. DOI: https://doi.org/10.3322/caac.21660
    [PubMed]     [Google Scholar]
    5. Elkordy AA, Haj-Ahmad RR, Awaad AS, Zaki RM. An overview on natural product drug formulations from conventional medicines to nanomedicines: Past, present and future. Journal of Drug Delivery Science and Technology. 2021 Jun 1;63:102459. DOI: https://doi.org/10.1016/j.jddst.2021.102459
    [Google Scholar]
    6. Wu C, Chen J, Lai-Han Leung E, Chang H, Wang X. Editorial: Artificial Intelligence in Traditional Medicine. Front Pharmacol. 2022 Aug 4;13:933133. DOI: https://doi.org/10.3389/fphar.2022.933133
    [PubMed]     [Google Scholar]